Fly News Breaks for May 2, 2019
May 2, 2019 | 06:34 EDT
JPMorgan analyst Robbie Marcus believes DexCom posted "another impressive quarter" and that its raised guidance still looks conservative. The analyst lowered his price target for the shares to $170 from $175 with peer multiples moving down year-to-date, but he continues to recommend the name with an Overweight rating.
News For DXCM From the Last 2 Days
There are no results for your query DXCM